Read More

Sanofi Makes Statement On FTC Challenge To Proposed License Agreement With Maze Therapeutics; Says We Respectfully Disagree With The Action By The FTC Which Also Delays Potential Advancements That Could Impact The Lives Of Patients

Sanofi is disappointed with the Federal Trade Commission's announcement that it is seeking a preliminary injunction against a proposed licensing agreement between Sanofi and Maze Therapeutics. The agreement, announced on

SNY